NCT06922539
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06922539
Title Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/ Refractory Small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors SciTech Development, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Southern California RECRUITING Los Angeles California 90007 United States Details
Henry Ford Cancer Institute RECRUITING Detroit Michigan 48202 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field